Abstract
P22 The mechanism for gender differences in cardiovascular disease may be due, in part, to differences in vascular function. Based on previous studies from our laboratory, we hypothesized that there is enhanced production of a vasoconstrictor cyclooxygenase product in arteries from males when compared to those from females. We studied three month-old male and female Sprague-Dawley rats (n=6 in each group). Small mesenteric arteries (∼400 μm) were isolated, pressurized, and the outer diameter was measured. Arteries from each rat were paired: one had intact endothelium (ENDO +) and the other was mechanically denuded (ENDO -). Dose-response curves to the α 1 -adrenergic agonist, phenylephrine (PE), were performed in the absence and presence of the cyclooxygenase inhibitor, indomethacin (INDO; 10 μM). Negative log EC 50 values were calculated as an index of PE sensitivity and compared between groups using ANOVA and lsd. There were no differences in the sensitivity to PE in ENDO + arteries from males (6.07±0.07) and females (6.12±0.10, p=0.93). In ENDO + arteries from females, the PE sensitivity was unchanged in the presence of INDO (6.11±0.13, p=0.94 when compared to control). However, INDO significantly decreased PE sensitivity in ENDO + arteries from males (5.70±0.08, p=0.01 when compared to control). Endothelium denudation had no significant effect on PE sensitivity in males or females. In denuded arteries from females, INDO produced no change in PE sensitivity (denuded female: 6.08±0.09, denuded + INDO: 5.88±0.13, p=0.23). In contrast, INDO produced a significant decrease in sensitivity in denuded arteries from males (denuded male: 6.33±0.14, denuded + INDO (5.94±0.09, p=0.03). The magnitude of the shift in PE sensitivity produced by INDO (Δ EC 50 )in males was equivalent in ENDO + (0.37±0.07) and ENDO - (0.39±0.09, p=0.9, Student’s t-test) arteries. In conclusion, arteries from male rats produce more of an indomethacin-sensitive vasoconstrictor factor than arteries from female rats. The site of enhanced production of this cyclooxygenase product in males is not the endothelium, but may be vascular smooth muscle.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.